As of 2025-10-20, the EV/EBITDA ratio of Twist Bioscience Corp (TWST) is -20.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Twist's latest enterprise value is 1,498.36 mil USD. Twist's TTM EBITDA according to its financial statements is -71.47 mil USD. Dividing these 2 quantities gives us the above Twist EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 16.1x | 14.6x |
| Forward P/E multiples | 15.2x - 17.6x | 15.8x |
| Fair Price | (14.64) - (15.73) | (14.66) |
| Upside | -152.0% - -155.8% | -152.1% |
| Date | EV/EBITDA |
| 2025-10-17 | -20.96 |
| 2025-10-16 | -23.15 |
| 2025-10-15 | -24.24 |
| 2025-10-14 | -22.98 |
| 2025-10-13 | -22.64 |
| 2025-10-10 | -23.52 |
| 2025-10-09 | -24.12 |
| 2025-10-08 | -24.88 |
| 2025-10-07 | -23.46 |
| 2025-10-06 | -24.08 |
| 2025-10-03 | -23.42 |
| 2025-10-02 | -23.09 |
| 2025-10-01 | -21.89 |
| 2025-09-30 | -20.95 |
| 2025-09-29 | -19.99 |
| 2025-09-26 | -19.91 |
| 2025-09-25 | -19.77 |
| 2025-09-24 | -20.00 |
| 2025-09-23 | -20.53 |
| 2025-09-22 | -20.67 |
| 2025-09-19 | -20.74 |
| 2025-09-18 | -20.79 |
| 2025-09-17 | -19.96 |
| 2025-09-16 | -20.05 |
| 2025-09-15 | -18.90 |
| 2025-09-12 | -18.56 |
| 2025-09-11 | -18.81 |
| 2025-09-10 | -17.59 |
| 2025-09-09 | -18.37 |
| 2025-09-08 | -19.35 |
| 2025-09-05 | -18.94 |
| 2025-09-04 | -18.83 |
| 2025-09-03 | -19.14 |
| 2025-09-02 | -19.34 |
| 2025-08-29 | -19.96 |
| 2025-08-28 | -19.64 |
| 2025-08-27 | -20.15 |
| 2025-08-26 | -20.59 |
| 2025-08-25 | -20.31 |
| 2025-08-22 | -21.33 |
| 2025-08-21 | -19.54 |
| 2025-08-20 | -19.52 |
| 2025-08-19 | -20.48 |
| 2025-08-18 | -20.85 |
| 2025-08-15 | -20.93 |
| 2025-08-14 | -21.54 |
| 2025-08-13 | -21.38 |
| 2025-08-12 | -20.37 |
| 2025-08-11 | -20.52 |
| 2025-08-08 | -18.84 |